Connexin channels in the lining of small arteries that help control blood pressure
Connexin hemichannels: an unexplored critical component in endothelium of resistance arteries
This work looks at whether tiny channel proteins in the cells that line small arteries help control blood pressure, which matters for people with high blood pressure.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rutgers Biomedical and Health Sciences NIH-funded |
| Lab location | 1 site (Newark, UNITED STATES) |
| Project ID | NIH-11258525 on NIH RePORTER |
What this research studies
From my perspective as a patient, researchers are studying how endothelial cells (the cells that line small resistance arteries) use calcium signals to relax blood vessels. They will look specifically at TRPV4 channels and connexin (Cx43) hemichannels to see how these allow calcium entry and promote vessel relaxation. The team uses lab-grown cells and experiments on small blood vessels to see what happens when these channels are blocked or activated. The goal is to understand a basic mechanism that could point to new ways to treat high blood pressure.
Who could benefit from this research
Good fit: Ideal candidates for future related trials would be adults with high blood pressure or disorders of blood pressure regulation.
Not a fit: People without blood-pressure-related vascular problems or those needing immediate clinical treatment are unlikely to get direct benefit from this basic lab research.
Why it matters
Potential benefit: If successful, this research could reveal new targets for drugs to improve blood pressure control and reduce hypertension-related risks.
How similar studies have performed: Prior laboratory studies have shown TRPV4 and connexin proteins affect vessel relaxation, but the specific role of Cx43 hemichannels in this calcium entry pathway is relatively new and not yet tested in patients.
Where this research is happening
Newark, UNITED STATES
- Rutgers Biomedical and Health Sciences — Newark, United States (Active)
Researchers
- Principal investigator: Lillo Gallardo, Mauricio Alejandro — Rutgers Biomedical and Health Sciences
- Study coordinator: Lillo Gallardo, Mauricio Alejandro
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.